BIO

What is Biotechnology?

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...
BIO

New Report Finds Bioscience Sector Generates Over $3 Trillion for U.S. Economy

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic ...
BIO

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding today’s Executive Order on most favored nation:

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the ...
BIO

BIO Recognizes Industry Leaders for Groundbreaking Work in Agricultural, Environmental Biotech

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette ...
BIO

Biotech Sector Thrives, Generating Nearly $3 Trillion Economic Impact – New Report Shows

The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The new report, The U.S ...
BIO

Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO

The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace ...
BIO

New survey: U.S. biotechs warn tariffs could impede access to cures, stifle innovation

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...
BIO

BIO survey reveals dependence on Chinese biomanufacturing

Breaking: BIO has released the results of a survey revealing companies’ dependence on Chinese biomanufacturing. Yesterday, a busy day on Capitol Hill featured testimony from a BIO Board member and a ...
BIO

New USITC report shows "no credible evidence" supporting a TRIPs waiver expansion

The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to ...
BIO

BIO Statement to Senate Ag Committee Hearing on Farm Bill Rural Development & Energy Programs

BIO submitted a statement for the record to the Senate Committee on Agriculture, Nutrition and Forestry hearing titled "Farm Bill 2023: Rural Development and Energy Programs." BIO called for a "farm ...
BIO

New drug pricing deal could propel us "light years back into the dark ages of biomedical research"

Democratic lawmakers in the U.S. Senate advanced drug pricing legislation today that would drastically alter the Medicare program. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology ...
BIO

Third-Annual Report on Diversity, Equity, and Inclusion in Biotechnology Finds Improvements in Gender Parity; More Progress Needed in Racial and Ethnicity Representation

The third annual report that examines diversity, equity, and inclusion (DEI) in the biotechnology industry launched today at the 2022 BIO International Convention. The report, “Measuring Diversity in ...